Results 21 to 30 of about 7,334 (206)
Minoxidil in androgenic alopecia: New formulations with Improved delivery [PDF]
المجلة العراقية للصيدلة, 2022 Background: Minoxidil was introduced into the market as a hypotensive agent, however, aftermarketing, the hypertrichosis side effect was reported by almost all users. This adverse effect encourages the repositioning or repurposing the use of minoxidil as
Alaa Al-taie +2 more
doaj +1 more source
Acne Scar Management: Minoxidil as a Promising Approach or a Mirage? [PDF]
International Journal of Biomedicine, 2023 Atrophic and hypertrophic scars can result from various conditions, such as acne, trauma, and surgery. Minoxidil, a medication used for the treatment of severe hypertension and hair loss, has been explored as a potential treatment for scars.
Ramadan S. Hussein, Salman Bin Dayel
doaj +1 more source
Pharmaceutics, 2022 The purpose of this study was to evaluate mechanisms behind the intestinal permeability of minoxidil, with special emphasis on paracellular transport, and elucidate the suitability of minoxidil to be a reference drug for Biopharmaceutics Classification ...
Milica Markovic +6 more
doaj +1 more source
Minoxidil and Dexamethasone Eluting Nanofiber Dressing for Cutaneous Wound Healing in Rat [PDF]
Pharmaceutical Sciences, 2023 Background: Minoxidil is an antihypertensive agent and vasodilator which may help to promote local blood flow thus hastening the closure of excisional skin wounds. Corticosteroids may down-regulate wound healing.
Saber khozan +4 more
doaj +1 more source
Successful management of suspected minoxidil toxicosis in a cat following accidental dermal exposure
Veterinární Medicína, 2022 Minoxidil was originally introduced as a potent vasodilator, but is now widely used as a topical treatment for human alopecia. A 4-year-old neutered male Norwegian Forest cat presented with a 2-day history of anorexia, lethargy, and dyspnoea.
Song JH, Kim SY, Moon JH, Jung DI
doaj +1 more source
Could Topical Minoxidil Cause Non-Arteritic Anterior Ischemic Optic Neuropathy? [PDF]
Journal of Clinical and Diagnostic Research, 2016 Minoxidil hair formulation is commonly used for the treatment of male or female androgenic alopecia. Minoxidil is a Health Canada and US FDA-approved medication for hair loss in men and women. The drug is marketed as 2% and 5% topical solutions.
Habibullah Aktas +3 more
doaj +1 more source
Characterization of Soluplus/ASC-DP Nanoparticles Encapsulated with Minoxidil for Skin Targeting
ChemEngineering, 2021 Soluplus (Sol) is an amphiphilic graft copolymer capable of forming self-assembled micelles and L-ascorbyl 2,6-dipalmitate (ASC-DP) aggregates spontaneously to form micelles.
Rina Takayama +4 more
doaj +1 more source
Pharmaceutics, 2018 In this work, we examined enhanced skin delivery of minoxidil applied in nanoemulsions incorporating skin penetration enhancers. Aliquots of fully characterized oil-in-water nanoemulsions (1 mL), containing minoxidil (2%) and the skin penetration ...
Eman Abd +3 more
doaj +1 more source
Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, 2023 The treatment and prevention of hair loss have been a serious aesthetic problem for the population for a long time due to the widespread occurrence of the condition and its undesirable medical and social consequences.
V. V. Hladyshev +6 more
doaj +1 more source
Dermatology and Therapy, 2023 Introduction This study assessed the levels of compliance to topical minoxidil (TM) among male and female patients with androgenetic alopecia (AGA) and analyzed the factors associated with minoxidil discontinuation.
Zari Shadi
doaj +1 more source